Denali CEO Ryan Watts Gifts 32,220 Shares

What Happened
Ryan J. Watts, President, CEO and a director of Denali Therapeutics (DNLI), disposed of 32,220 shares on August 12, 2026 via a gift. The Form 4 lists the transaction as a gift (code G) with a reported price and total value of $0.00, reflecting an in‑kind charitable contribution rather than a market sale.

Key Details

• Transaction date: 2026-08-12; Form 4 filed: 2026-08-14 (filed within the typical two-business-day window).
• Transaction type: Gift (G); shares disposed: 32,220; reported price/value: $0.00 (in‑kind charitable contribution).
• Record ownership: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015; the reporting person serves as trustee (Footnote F2).
• Additional holdings: Filing notes include 184,915 unvested RSUs (Footnote F3).
• Shares owned after the transaction are not specified on the summary data in this notice.

Context
Gifts to donor‑advised funds or charities are common insider transactions and do not necessarily signal the insider’s market view of the company. This was a non‑cash charitable transfer of shares held in a family trust; no sale proceeds to the insider were reported.